While A-SAA is largely regarded as an atherosclerosis disease biomarker (49), growing evidence suggests that SAA is not merely a passive participant but rather plays an active role in the formation of atherosclerotic plaques through the modulation of several disease-related pathways. The gene discussed is SAA2; the disease is atherosclerosis.